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Abstract 
 
Purpose: In gingival squamous cell carcinoma (GSCC), the association between survival and history of 
dental extraction (DE) is controversial. The purpose of this study was to investigate the prognosis for 
patients in whom GSCC was detected after DE was performed. 
Patients and Methods: DE for GSCC tumor symptoms was performed in 19 patients before diagnosis (DE 
group) and not in 58 patients (non-DE group). The clinical features, characteristics, and prognosis were 
evaluated statistically between the two groups. 
Results: The interval between DE and the first visit to our hospital was 1.1-97 weeks (median 7.3 weeks). 
There was no significant difference in T status, N status, local recurrence, pathologically positive lymph 
nodes, or distant metastasis between the DE and non-DE groups. Bone invasion was observed 
radiographically in six patients with mandibular GSCC in the DE group (100%) and 13 in the non-DE 
group (68.4%). There was a significant difference in bone invasion between the DE and non-DE groups 
(P<0.01). Segmental mandibulectomy was performed in 11 patients (84.6%) in the DE group and 21 
patients (61.8%) in the non-DE group. The extent of resection tended to be larger for the DE group. The 
5-year overall survival rate was 84.6% for the DE and 65.8% for the non-DE patients with mandibular 
GSCC. For maxillary GSCC, the survival rates differed significantly between the groups (33.3% in the DE 
and 73.7% in the non-DE group). 
 Conclusions: For mandibular GSCC, the resection field was appropriate for the extent of bone invasion 
after DE, and the prognosis was similar to that in the non-DE group. For maxillary GSCC, a broad surgical 
field is suggested because of the potential for rapid spread in cancellous bony trabeculae.   
 
 
Key Words: Dental extraction (DE), Gingival squamous cell carcinoma (GSCC), Survival rate, Prognosis, 
Surgical field 
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Introduction 
    Teeth that are in close proximity to a carcinoma can be associated with swelling, pain, and loosening, 
and may thus be erroneously extracted because of suspected periodontitis or pericoronitis by the dental 
general practitioner. Suzuki et al. reported that, compared to a group of patients in whom dental extraction 
(DE) was not performed, the incidence of pathologically positive lymph nodes was significantly higher and 
the five-year survival rate lower in a DE-treated group.1 Moreover, when DE is performed for incorrectly 
diagnosed periodontitis or pericoronitis, the correct diagnosis and appropriate treatment may be delayed, 
resulting in a worse prognosis. Previous studies suggest that the risks of gingival squamous cell carcinoma 
(GSCC) recurrence, cervical lymph-node metastasis, and distant metastases are increased in patients with a 
history of DE. 1, 2  
   However, the association between survival and a history of DE remains controversial. Other researchers 
have reported that DE does not influence local control, lymph-node metastasis, distant metastasis, or 
disease-specific survival prior to definitive treatment. 3-5 Lubek et al. reported that previous DE, which can 
potentially seed the open socket with cancer cells and allow deep bony involvement, was not a significant 
variable. 6 Thus, although the risks of DE have been emphasized, its effects on the metastasis and prognosis 
of patients have not been well documented. This study was carried out to investigate the prognosis of 
GSCC detected after DE was performed at the site of the carcinoma. 
 
Patients and Methods 
 Subjects   
   Seventy-seven patients, 45 men and 32 women, in whom GSCC was diagnosed at the Department of 
Oral and Maxillofacial Surgery, University of Tsukuba Hospital, between 1997 and 2008, were 
retrospectively enrolled as subjects. All the cases were reviewed for an approximately 5-year period after 
each patient’s first visit or radical treatment. Patients’ ages ranged from 40 to 88 years, with a median of 70 
years. The primary tumor site was the maxilla for 25 cases and the mandible for 52 cases. Each patient’s 
cancer was staged according to the 1997 International Union Against Cancer (UICC) categories. The 
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treatment modality given for the primary tumor included surgery, radiotherapy, chemotherapy, or a 
combination. The primary tumor was excised with a safety margin greater than 10 mm in all directions. The 
extent of bone resection (marginal or segmental) was based on the extent of the soft-tissue tumor and of the 
radiographically determined bone invasion. 
   DE within the tumor was performed in 19 patients (24.7%) before diagnosis (DE group) and was not 
performed in 58 patients (75.3%) (non-DE group). The clinical features, characteristics, and prognosis were 
evaluated for statistical differences between the two groups. The patients’ data were examined 
retrospectively by reviewing their medical records. Due to the retrospective nature of this study, it was 
granted an exemption in writing by the University of Tsukuba Hospital. The following information was 
obtained: age, sex, site of primary tumor (maxilla or mandible), locoregional treatment, history of DE 
before diagnosis, symptoms at first visit, and 5-year survival rate according to the primary tumor site. 
 
Statistical analysis 
   Survival curves were calculated by the Kaplan-Meier method, and difference in the survival rate was 
determined with the Log-rank test. The Mann-Whitney U-test and Chi square test were used in statistical 
comparisons between the DE group and non-DE group. All statistical analyses were performed with the Stat 
View J 5.0 software package (SAS Institute Inc, Chicago IL). Differences with a p-value less than 0.05 
were considered statistically significant.   
 
Results 
 
1. Patient characteristics  
   The tumor status in the DE group was T2 for 5 patients, T3 for 4, and T4 for 10; in the non-DE group, it 
was T1 for 3 patients, T2 for 22, T3 for 9, and T4 for 24. The node status in the DE group was N0 for 11 
patients, N1 for 4, and N2b for 4; in the non-DE group, it was N0 for 37 patients, N1 for 6, N2b for 10, and 
N2c for 5. The cancer stage in the DE group was stage II for 3 patients, stage III for 4, and stage IV for 12; 
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in the non-DE group, it was stage I for 1 patient, stage II for 20, stage III for 8, and stage IV for 29. There 
was no significant difference in stage classification between the DE and non-DE groups (Table 1).    
 
2. Patients undergoing DE before diagnosis and clinical features of both groups at first visit  
   DE within the tumor was performed in 19 patients before GSCC was diagnosed, at another hospital. 
The interval between DE and the first visit to our hospital was 1.1-97 weeks, with a median of 7.3 weeks. 
The extraction site was the maxilla in 6 patients (11 teeth) and the mandible in 13 patients (19 teeth). The 
tooth position was anterior in 3 patients (7 teeth) and molar in 16 patients (23 teeth).  
   The major symptom was swelling in both the DE and non-DE groups (52.6%, 53.4%). Pain (21.1%) 
and delay of extraction site healing (15.8%) were the next most common symptoms in the DE group. Poor 
denture fit (15.5%) and ulceration (12.1%) were the next most common symptoms in the non-DE group.     
   Radiographically, bone invasion was observed in all the patients in the DE group and in 37 patients 
(63.8%) in the non-DE group. Bone invasion of mandibular GSCC was observed in 6 patients (100%) in 
the DE group and 13 patients (68.4%) in the non-DE group. There was a significant difference in the bone 
invasion between the DE and non-DE groups (P<0.01) (Table 2).  
 
3. Locoregional treatment and surgical procedure  
    The locoregional treatment in the DE group was surgery for 13 patients, pre-surgical radiotherapy and 
surgery for 4, surgery and post-surgical radiotherapy for 1, and radiotherapy for 1; in the non-DE group, the 
treatment was surgery for 31 patients, pre-surgery radiotherapy and surgery for 17, surgery and post-surgery 
radiotherapy for 2, and radiotherapy for 8 (Table 1). There was no significant difference in any of these 
factors between the two groups. 
   Surgery was performed in 21 patients with GSCC of the maxilla and 47 with GSCC of the mandible. 
Marginal mandibulectomy was performed in 2 patients (15.4%) in the DE group and 13 (38.2%) in the 
non-DE group. Segmental mandibulectomy was performed in 11 patients (84.6%) in the DE group and 21 
(61.8%) in the non-DE group. Although the extent of resection tended to be larger for the DE group, the 
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difference between the groups was not statistically significant. The surgical procedure for the maxilla is 
shown in Table 3. Neck dissection was performed in 11 patients in the DE group and 25 patients in the 
non-DE group (Table 3). 
   Pathologically, the surgical margin was free of cancer in 16 patients (88.9%) in the DE and 43 patients 
(86.0%) in the non-DE group. Two patients in the DE and 7 patients in the non-DE group had a positive or 
close margin within 5 mm. Of the patients treated surgically, bone invasion was observed in 15 (83.3%) in 
the DE group and 30 (60.0%) in the non-DE group. There was difference in bone invasion between the DE 
and non-DE groups was not significant (Table 4).  
 
4. Postsurgical course and survival rate of each group 
  Sixteen patients had a local recurrence during the postsurgical course (4 patients in the DE group and 
12 in the non-DE group); 8 had late neck metastasis, and 9 had distant metastasis. The difference in 
postsurgical course between the DE and non-DE groups was not statistically significant (Table 5). 
Pathologically positive lymph nodes were observed in 5 patients (27.8%) in the DE group (range 1 to 3, 
median of 2 lymph nodes) and 12 patients (24.0%) in the non-DE group (range 1 to 4, median of 1.5 lymph 
nodes) (Table 4).   
  The 5-year overall survival rate was 68.4% in the DE group and 68.6% in the non-DE group among all 
the GSCC patients, which was not significantly different. For maxillary GSCC, the survival rate was 33.3% 
in the DE group and 71.8% in the non-DE group, which did reach significance (p<0.05) (Table 6, Fig 1). 
Among the mandibular gingival cancer patients, the survival rate was 84.6% in the DE group and 65.8% in 
the non-DE group, which was not significantly different (Table 6, Fig 2). 
 
Discussion 
    Pain is reported to be the most common clinical feature of GSCC diagnosed after DE, present in all 
such cases. 7 In our study, pain was a symptom in 21.1% of the patients in the DE group, consistent with the 
previous report, and 8.6% in the non-DE group. The duration of symptoms before DE is reported to range 
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from 3 weeks to 20 months, with most patients seeking treatment at 3 months. 7 The mean time interval 
between DE and histologic diagnosis in a previous report was 63 days (9 weeks) with a range of 3 to 260 
days (0.4-37 weeks). 1 In this study, the interval between DE and the first visit was 1.1-97 weeks, with a 
median of 7.3 weeks. Symptoms appeared in these patients about 2 months after DE, which was almost the 
same as in previous reports. This delay may be one of the factors that facilitate tumor dissemination. Suzuki 
et al. suggested that the delay in symptoms increases the risk of lymph-node metastasis and contributes to a 
poor prognosis. 1 In the present study, it was not clear whether this delay affected the lymph-node 
metastasis or prognosis. 
    The association between prognosis and history of DE remains controversial. It has been hypothesized 
that a history of previous DE worsens the prognosis, and neck node metastasis was reported to be more 
frequent in patients who underwent DE. 1 However, other authors reported that cervical lymph node 
metastasis was not significantly different between patients who underwent an invasive procedure and those 
who did not. 3, 5 In addition, statistically significant differences were not found in the tumor recurrence rate, 
cervical recurrence, distant metastasis, or 5-year survival rate. 3, 5 Lubek et al. reported that previous DE, 
which can theoretically seed the open socket and allow deep bony involvement, was not a significant 
variable for the prognosis for gingival carcinoma. 6 In the present study, we found no differences in the T 
status, N status, local recurrence, or distant metastasis with or without DE. Mandibular GSCC showed 
almost the same prognosis in the DE and non-DE groups. These results supported the latter opinions. On 
the other hand, there was a significant difference in the survival rate of patients with maxillary GSCC 
between the DE and non-DE groups. However, the sample size was small for the maxillary cases, and 
further studies with a larger number of cases at this primary site will be required to clarify the difference.  
      In a previous report, advanced clinical stage III and IV, previous DE, bony invasion, and invaded 
margins were associated with worse survival in a univariate analysis. 8 Only the difference in advanced 
stage was significant in multivariate analysis, but lymph-node involvement was not studied separately. 8 
Although bone invasion is reported to be a predictive factor, a recent study showed that tumors with bone 
invasion limited to the cortex have a similar prognosis to those without bone invasion.9 Surgical 
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invasiveness in oral cancer, including biopsy, causes the dissemination of cancer cells into the circulation, 
increasing the risk for metastasis. 2 In general, cervical lymph-node metastasis is one of the most significant 
factors affecting the prognosis of head and neck cancer. In the present study, the incidence of cervical 
lymph-node metastasis was 42.1% in the DE group and 36.2% in the non-DE group, which, although it was 
not significantly different, could have affected the overall survival rates of these two groups. On the other 
hand, another group reported that the disease-specific survival rates of two groups that had or had not 
undergone surgical procedures before GSCC treatment were not significantly different. This conclusion was 
based on the extent of resection needed for the primary tumor. 4 Cancer bone invasion is a well-known 
predictive factor for survival. 8 Hong et al. advised using more aggressive resection, when a GSCC in the 
dentate mandible remains undiagnosed for a few months after inadvertent DE or when a secondary surgical 
manipulation was previously carried out at the tumor site.10 When the malignant tumor is related to 
previous DE or curettage, it tends to be more extensive than predicted from imaging. If mandibular invasion 
by GSCC is identified radiographically and clinically, segmental mandibulectomy is required for an 
adequate safety margin, considering the spreading pattern in the molar region. 10 In the present mandibular 
GSCC cases, previous DE did not affect the T stage. The resection field in the patients who received DE 
tended to be broader; for instance, the proportion of patients who received segmental mandibulectomy was 
84.6% in the DE group versus 61.8% in the non-DE group. In addition, the extent of radiographically 
detected bone invasion was significantly greater in the DE group. Although the extent of bone resection was 
determined from clinical and radiographic criteria, surgeons may have believed that the DE patients had 
more locally disseminated microscopic disease, leading them to choose segmental mandibulectomy. This 
choice may have biased the data to some extent. Thus, the extended resection field might have been related 
to the lack of significant difference in the 5-year overall survival rate between the two groups.  
   In the cases of maxillary GSCC, there was a significant difference in the survival rates, 33.3% in the DE 
group and 73.7% in the non-DE group. Although the T status as detected by CT or MRI was not affected in 
the DE group, it is likely that microscopic GSCC extended into the cancellous bone of the maxilla. 
According to a report, the extent of bony invasion diagnosed clinically and radiographically often does not 
 9 
correspond to that found histologically.11 It is difficult to determine the appropriate resection margin, 
because bone invasion by cancer cells whose spreading is transmedullary is not radiologically identifiable. 
Moreover, tumor cells spread rapidly between cancellous bony trabeculae, since they meet no resistance or 
barrier. In our study, the sample size of maxillary cases was small, and further study with a larger number of 
cases at this primary site will be required to clarify the differences.  
   Choi et al. recommended that after invasive procedures, more aggressive treatment for gingival cancer, 
such as setting a broad surgical field and enforcing preventive neck dissection, are needed to improve the 
outcome. 5 In cases of maxillary GSCC, we agree with their recommendation, because of the possibility for 
rapid spreading between cancellous bony trabeculae in the maxilla, and because of our finding of a poor 
prognosis. However, the prognosis in the mandibular GSCC cases was not significantly different between 
the two groups, and the resection was performed according to the extent of the cancer based on 
radiographic findings. Moreover, the frequency of cervical lymph node metastasis between the DE and 
non-DE groups did not differ significantly in our study. Therefore, we believe that the extent of resection 
for mandibular GSCC and neck dissection corresponding to the usual field of resection, not aggressive 
resection, is appropriate. 
    GSCC mimics periodontitis and pericoronitis. DE performed without awareness of the carcinoma may 
cause a delay in reaching the correct diagnosis and starting appropriate treatment, and thereby worsen the 
prognosis. A larger lesion may raise the suspicion of neoplasm, thus resulting in a referral before extraction 
or treatment, whereas a smaller lesion may be suspected of being non-malignant. In the case of maxillary 
GSCC, we recommend setting a broad surgical field, because of the possibility of rapid spread between 
cancellous bony trabeculae. For mandibular GSCC, we set the resection field according to the extent of 
invasion for both groups, and the prognosis was almost the same for the DE and non-DE groups.   
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Table 1. Patient characteristics 
 
Characteristics                                 No. of patients (%) 
                                 DE group, n= 19          Non-DE group, n=58   
 
Sex   
  Male/Female                         11/ 8                  34/ 24 
Age (years) 
 Median (range)                       75 (40-84)              70 (47-88) 
Primary tumor site 
 Maxillary gingiva             6 (31.6)               19 (32.8) 
 Mandibular gingiva           13 (68.4)               39 (67.2) 
Tumor status  
 T1                                  0  (0)                 3 ( 5.2) 
 T2                                  5 (26.3)               22 (37.9) 
   T3                                  4 (21.1)                9 (15.5) 
 T4                                 10 (52.6)               24 (41.4) 
Node status  
   N0                                  11 (57.9)               37 (63.8) 
   N1             4 (21.1)                 6 (10.3) 
 N2a                                  0  (0)                  0  (0) 
 N2b                                  4 (21.1)                10 (17.2) 
 N2c                                  0  (0)                  5 (8.6) 
 N3                                   0  (0)                  0  (0) 
Stage classification 
 I                                    0  (0)                 1  (1.7) 
 II                                   3 (15.8)                20 (34.5) 
 III                                  4 (21.1)                 8 (13.8)        
 IV                                 12 (63.2)                29 (50.0)            
Locoregional treatment 
   S                                  13 (68.4)                31 (53.4) 
   R+S                                4 (21.1)                 17 (29.3) 
   S+R                                1  (5.3)                 2  (3.4) 
   R                                  1  (5.3)                 8 (13.8) 
 
S: Surgery; R: Radiotherapy 
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Table 2. Clinical and radiographic features at first visit  
 
                                      No. of patients (%) 
                           DE group, n= 19    Non-DE group, n=58 
 Clinical feature                 
  
 Swelling   10 (52.6)   31 (53.4) 
 Pain     4 (21.1)    5 (8.6) 
 Delay of extraction site healing 3 (15.8)    0 (0) 
 Poor denture fit                 1 (5.3)    9 (15.5) 
 Ulceration   0  (0)    7 (12.1) 
 White lesion   1 (5.3)    2 (3.4) 
 Tooth mobility   0  (0)    2 (3.4) 
 Other     0  (0)    2 (3.4) 
 
 Bone invasion by radiography 19 (100)    37 (63.8)     P<0.01 
   Maxilla    6    13             n.s. 
   Mandible          13    24      P<0.01 
 
  n.s.: Not significant 
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Table 3.  Surgical procedure 
 
          No. of patients (%)                              
    DE group, n=19             Non-DE group, n=58          
                                   
 
Maxilla      Partial resection  5 (100)   14 (87.5)   
(n=21)       Total maxillectomy  0  (0)    2 (12.5)          
 
Mandible     Marginal resection  2 (15.4)    13 (38.2)   
(n=47)       Segmental resection  11(84.6)   21 (61.8)               
 
No surgery    1   8 
(n=9) 
 
Neck dissection    11                     25                     
(n=36) 
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Table 4. Association between pathological findings and dental extraction in patients treated with 
surgery  
          
                                           No. of patients  (%) 
                                DE group, n= 18  Non-DE group, n=50           
 
 Positive lymph nodes                     5 (27.8)   12 (24.0)  
    (n=36) 
 Surgical margin <5mm    2 (11.1)    7(14.0)      
    (n=9) 
 Bone invasion                          15 (83.3)               30 (60.0)          
    (n=45)   
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Table 5. Association between post-treatment factors and dental extraction 
 
                    
                 No. of patients  (%) 
                                DE group, n= 19  Non-DE group, n=58           
 
 
 Local recurrence                        4 (21.1)   12 (20.7)                   
  
 Late neck metastasis                     3 (15.8)   5 ( 8.6)                   
  
 Distant metastasis       2 (10.5)   7 (12.1)                  
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Table 6. Five-year overall survival rate of each group 
 
    Primary                      5-year overall survival rate (%)             
                            DE group         Non-DE group      P 
   
    Maxilla                    33.3                71.8            <0.05 
 
    Mandible                   84.6                65.8              n.s. 
 
    All                        68.4                68.6              n.s. 
 
 
n.s.: Not significant 
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FIGURE 1. Survival rate of patients with maxillary GSCC. (Red line: Non-DE group, Blue line: DE 
group) 
There was a significant difference in the survival rate between the DE and non-DE groups. (P<0.05)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 18 
 
FIGURE 2. Survival rate of patients with mandibular GSCC. 
         (Red line: Non-DE group, Blue line: DE group) 
 
 
